“Maximizing the full potential of others”

DYNALABS’ own Nichole DiLoretta was nominated to be one of the Wonder Women for St. Louis Small Business monthly. We very proud of her and her devotion to us here at DYNALABS but to the people she helps outside the work place. Nice Work Nicole!

Read More

Announcing a new National Accounts Manager, Christine Versichele.

In this role, Christine’s focus will be working directly with strategic multi-national and global accounts within the pharmaceutical compounding industry. This focus is consistent with DYNALABS’ business model for sustainable accelerated growth. We believe Christine’s vast industry knowledge and experience will serve her well in identifying new opportunities and developing cost-effective custom solutions. As National Account Manager, Christine will further promote DYNALABS’ guiding principles – Patient Safety, Affordable Healthcare, and Business Success – within the…

Read More

Using USP to determine Microbial Enumeration

DYNALABS provides USP <61> as the pinnacle test to determine Microbial Enumeration (aka bioburden) in non-sterile samples. This microbial analysis acts as a quasi-sterility test with an expected CFU count for monitoring the microbiological profile of a product’s ingredients and of finished products.

Read More

DYNALABS announces Director of Quality & Regulatory Affairs

DYNALABS LLC is pleased to announce Nichole DiLorretta as our Director of Quality & Regulatory Affairs. Nichole is responsible for daily QA operations as well as corporate projects related to quality and regulatory compliance. Nichole holds a Bachelor of Science in Biology, with an emphasis in Biochemistry from Southern Illinois University. She holds Forensic Science and Forensic Chemistry and Analysis certification from Saint Louis University.

Read More

DYNALABS Announces New President

We’re pleased to announce that Jun Fabella has accepted the position of President of DYNALABS. For some time now, Jun has been leading the drive to expand our infrastructure with the goal of enhancing our efficiencies and processes. In doing so, he has been executing the DYNALABS’ philosophy of ‘relentless pursuit of excellence’.

Read More

DYNALABS Enhances Antimicrobial Effectiveness Testing for USP

Through the continuing enhancement of our internal systems and sample receipt processes, the testing for USP <51> has seen a significant reduction of time in receiving these test results.

Antimicrobial Effectiveness testing is performed to determine the efficacy of preservatives within a compound against specific challenge organisms. DYNALABS’ AE testing procedure is based on USP chapter 51 guidelines. This test is used for testing multi-dose pharmaceuticals and products.

Testing for USP<51> requires Suitability Testing and will also require the preservative to be declared on the samples labeling. Required sample amount(s) for the routine testing will be based upon the preservative indicated.

Read More

Custom Packing Slip

Improvements to our Test Request processs For reference, you may download an example of the packing slip by clicking here. If you have any questions at all please reach out to us at The DYNALABS’ online Test Request process will soon generate automatically a custom packing slip. You enter no additional data; the information needed for the packing slip has already been entered as part of the normal sample submission web pages; all you…

Read More

DYNALABS Receives ISO/IEC 17025 Accreditation

St. Louis, Missouri – DYNALABS is pleased to announce that the American Association for Laboratory Accreditation (A2LA) has approved our company for ISO/IEC 17025 accreditation. To gain the accreditation, DYNALABS underwent a thorough assessment of its quality management processes, and competency to perform analytical and microbiological testing on pharmaceutical raw materials and compounded drug products.

Read More